Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 9 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  2. US 7396927

    Process for preparation of rosuvastatin calcium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  3. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  4. US 7390807

    Crystal forms of lamotrigine and processes for their preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  5. US 7368468

    Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  6. US 7368606

    Amorphous cinacalcet hydrochloride and preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  7. US 7361756

    Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted
  8. US 7357945

    Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  9. US 7358390

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  10. US 7358360

    Risedronate sodium having a very low content of iron

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  11. US 7342120

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  12. US 7335685

    Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  13. US 7332612

    Amorphous and crystalline forms of losartan potassium and process for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted
  14. US 7323459

    Crystal forms, methods for their preparation and method for preparation of olanzapine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted
  15. US 7319171

    Sertraline hydrochloride form II and methods for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted
  16. US 7312340

    Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted
  17. US 7301024

    Crystalline forms of gatifloxacin and processes for preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted
  18. US 7294687

    Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  19. US 7294735

    Purification of cinacalcet

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  20. US 7291614

    Processes for the preparation of linezolid intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  21. US 7276629

    Hydrogenation of imine intermediates of sertraline with catalysts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted
  22. US 7256212

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  23. US 7256195

    Preparation of risperidone

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  24. US 7247751

    Processes for preparing cinacalcet hydrochloride crystal Form I

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted